Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.30), $0.15 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.